Clinical Trial Update: Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating betahistine for treating adults with attention-deficit/hyperactivity disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Betahistine (betahistine)

Snippet

Sponsor: P2D, Inc. | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 1 | Status: COMPLETED